Herbal Medicines in Pediatric Neuropsychiatry

Pediatric Clinics of North America

Volumn 58, Issue 1, 2011, Pages 33-54

  Feucht, Cynthia ^a,b   Patel, Dilip R ^c  

^a Borgess Ambulatory Care   (United States)

^b FERRIS STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adolescent; Complementary medicine; Herbal supplement; Neuropsychiatric; Pediatric

Indexed keywords

BIOFLAVONOID; CAFFEINE; CHITOSAN; CHROMIUM PICOLINATE; DOCOSAHEXAENOIC ACID; ESSENTIAL OIL; GARCINIA CAMBOGIA EXTRACT; GINKGO BILOBA EXTRACT; GUARANA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; ICOSAPENTAENOIC ACID; KAVA; KAWAIN; LEMON OIL; MELATONIN; PHYTOSTEROL; PLACEBO; PLANT GLYCOSIDE; PYRUVIC ACID; RESIN; SAPONIN; SOUR ORANGE EXTRACT; TERPENE; VALERIAN;

ABNORMAL FECES; ACUTE HEPATITIS; AGITATION; ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ASTHMA; ATTENTION DEFICIT DISORDER; BACTERIAL INFECTION; BEDTIME DOSAGE; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CHILD HEALTH CARE; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CHRONIC DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; CONSTIPATION; CONTACT ALLERGY; CONVULSION; COUGHING; CROHN DISEASE; DEPRESSION; DERMATITIS; DEVELOPMENTAL DISORDER; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG CONTAMINATION; DRUG CONTRAINDICATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INFORMATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG PROTEIN BINDING; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG USE; DRUG WITHDRAWAL; DYSKINESIA; DYSLEXIA; ECZEMA; EPILEPSY; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; EYE DISEASE; FATIGUE; FIRST PASS EFFECT; FLATULENCE; GASTROINTESTINAL SYMPTOM; GOVERNMENT REGULATION; HEADACHE; HEALTH CARE UTILIZATION; HEART PALPITATION; HEARTBURN; HEPATITIS; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IDIOPATHIC DISEASE; INFANTILE AUTISM; INFLAMMATORY DISEASE; INSOMNIA; INTELLECTUAL IMPAIRMENT; INTRACTABLE EPILEPSY; IRRITABILITY; JAUNDICE; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER NECROSIS; LIVER TOXICITY; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MOOD CHANGE; MOOD DISORDER; MUCOLYSIS; MUSCLE SPASM; NAUSEA; NAUSEA AND VOMITING; NEOPLASM; NERVOUSNESS; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PARESTHESIA; PARKINSON DISEASE; PATIENT COMPLIANCE; PEPTIC ULCER; PHOTODERMATOSIS; PHOTOSENSITIVITY; PHOTOSENSITIVITY DISORDER; PHYTOCHEMISTRY; PREMENSTRUAL SYNDROME; PROSTATE HYPERTROPHY; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; RESTLESSNESS; REVIEW; RISK BENEFIT ANALYSIS; SEASONAL AFFECTIVE DISORDER; SEDATION; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SINGLE DRUG DOSE; SKIN ALLERGY; SKIN DISCOLORATION; SKIN DISEASE; SLEEP DISORDER; STOMACH FUNCTION DISORDER; TACHYCARDIA; TASTE DISORDER; TREATMENT DURATION; TREMOR; VIVID DREAM; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; XERODERMA; XEROSTOMIA;

ADOLESCENT; CHILD; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HERB-DRUG INTERACTIONS; HERBAL MEDICINE; HUMANS; HYPERICUM; KAVA; MELATONIN; MENTAL DISORDERS; PHYTOTHERAPY; PLANT PREPARATIONS; VALERIAN;

EID: 79251561257     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2010.10.006     Document Type: Review

References (81)

1. National Center for Complementary and Alternative Medicine What is complementary and alternative medicine? Available at:, Accessed June 26, 2010. http://nccam.nih.gov/health/whatiscam/.
2. Breuner C. Alternative and complementary therapies. Adolesc Med 2006, 17:521-546.
3. National Center for Complementary and Alternative Medicine NCCAM Facts at a glance and mission Available at:, Accessed June 26, 2010. http://nccam.nih.gov/about/ataglance/.
4. Herbal practices in the US. Evidence-based herbal medicine 2002, 6-16. Hanley & Belfus, Philadelphia. M. Rotblatt, I. Ziment (Eds.).
5. US Department of Health and Human Services, US Food and Drug Administration Overview of dietary supplements Available at:, Updated October 14, 2009. Accessed July 6, 2010. http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110417.htm%23regulate.
6. Woolf A. Herbal remedies and children: do they work? Are they harmful?. Pediatrics 2003, 112:240-246.
7. Chemistry of herbal medications. Evidence-based herbal medicine 2002, 29-44. Hanley & Belfus, Philadelphia. M. Rotblatt, I. Ziment (Eds.).
8. Quality assurance and choosing a brand or product. Evidence-based herbal medicine 2002, 17-23. Hanley & Belfus, Philadelphia. M. Rotblatt, I. Ziment (Eds.).
9. Ernst E., Pittler M. Herbal medicine. Med Clin North Am 2002, 86(1):149-161.
10. Ernest E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 2003, 162:72-80.
11. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998, 104:170-178.
12. Cheng T., Wong R., Lin Y., et al. Chinese herbal medicine, sibship, and blood lead in children. Occup Environ Med 1998, 55:573-576.
13. Halt M. Moulds and mycotoxins in herb tea and medicinal plants. Eur J Epidemiol 1998, 14:269-274.
14. Huang W., Wen K., Hsaio M. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997, 37:334-350.
15. Vanherweghem J., Depierreux M., Tielmans C., et al. Rapidly progressive interstitial renal fibrosis in young women: association with a slimming regimen including Chinese herbs. Lancet 1993, 341:387-391.
16. Horowitz R., Dart R., Gomez H., et al. Epidemiologic notes and reports. Jin Bu Huan toxicity in children - Colorado, 1993. Morb Mortal Wkly Rep 1993, 42:633-636.
17. Farah M., Edwards R. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000, 9:105-112.
18. US Pharmacopeia USP verified Available at:, Accessed July 7, 2010. http://www.usp.org/USPVerified/.
19. Pitetti R., Singh S., Hornyak D., et al. Complementary and alternative use in children. Pediatr Emerg Care 2001, 17(3):165-169.
20. Yussman S., Ryan S., Auinger P., et al. Visits to complementary and alternative medicine providers by children and adolescents in the United States. Ambul Pediatr 2004, 4:429-435.
21. Lanski S., Greenwald M., Perkins A., et al. Herbal therapy use in a pediatric emergency department population: expect the unexpected. Pediatrics 2003, 111:981-985.
22. Wilson K., Klein J., Sesselberg T., et al. Use of complementary medicine and dietary supplements among U.S. adolescents. J Adolesc Health 2006, 38:385-394.
23. Barnes P., Bloom B., Nahin R. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008, 12:1-23.
24. Sikand A., Laken M. Pediatricians' experience with and attitudes toward complementary/alternative medicine. Arch Pediatr Adolesc Med 1998, 152:1059-1064.
25. Yager J., Siegfreid S., DiMatteo T. Use of alternative remedies by psychiatric patients: illustrative vignettes and a discussion of the issues. Am J Psychiatry 1999, 156:1432-1438.
26. Cala S., Crismon M., Baumgartner J. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy 2003, 23(2):222-230.
27. Wong V.C.N. Use of complementary and alternative medicine (CAM) in autism spectrum disorder (ASD): comparison of Chinese and western culture (part A). J Autism Dev Disord 2009, 39:454-463.
28. Soh N., Walter G. Complementary medicine for psychiatric disorders in children and adolescents. Curr Opin Psychiatry 2008, 21:350-355.
29. Natural Medicines Comprehensive Database. St. John's Wort Available at:, Accessed June 8, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=mhsla%7Ecp%26s=ND%26pt=9%26Product=st.%2Bjohn's%2Bwort%26btnSearch.x=0%26btnSearch.y=0.
30. St. John's Wort. Evidence-based herbal medicine 2002, 315-321. Hanley & Belfus, Philadelphia. M. Rotblatt, I. Ziment (Eds.).
31. Lawvere S., Mahoney M. St. John's wort. Am Fam Physician 2005, 72:2249-2254.
32. Charrois T., Sadler C., Vohra S. Complementary, holistic and integrative medicine: St. John's wort. Pediatr Rev 2007, 28(2):69-72.
33. Simeon J., Nixon M., Miulin R., et al. Open-label pilot study of St. John's wort in adolescent depression. J Child Adolesc Psychopharmacol 2005, 15(2):293-301.
34. Findling R., McNamara N., O'Riordan M., et al. An open-label study of St. John's wort in juvenile depression. J Am Acad Child Adolesc Psychiatry 2003, 42:908-914.
35. Izzo A., Ernst E. Interactions between herbal medicines and prescribed drugs, a systematic review. Drugs 2001, 61(15):2163-2175.
36. Yue Q.-Y., Bergquist C., Gerden B. Safety of St. John's wort (Hypericum perforatum). Lancet 2000, 355:576-577.
37. Lantz M., Buchalter E., Giambanco V. St. John's wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 1999, 12:7-10.
38. Melatonin. Altern Med Rev 2005, 10(4):326-336.
39. Natural Medicines Comprehensive Database Melatonin Available at:, Accessed August 30, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA%7ECP%26s=ND%26pt=9%26Product=melatonin%26btnSearch.x=0%26btnSearch.y=0.
40. Shamseer L., Vohra S. Complementary, holistic and integrative medicine: melatonin. Pediatr Rev 2009, 30(6):223-228.
41. Wagner J., Wagner M., Hening W. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 1998, 32:680-691.
42. Sheldon S. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998, 351:1254.
43. Peled N., Shorer Z., Peled E., et al. Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia 2001, 42:1208-1210.
44. Buscemi N., Vandermeer B., Hooton N., et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 2005, 20:1151-1158.
45. Phillips L., Appleton R. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol 2004, 46:771-775.
46. Bendz L., Scates A. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother 2010, 44:185-191.
47. Plushner S. Valerian: Valeriana officinalis. Am J Health Syst Pharm 2000, 57:333-335.
48. Valerian (Valeriana officinalis). Evidence-based herbal medicine 2002, 355-359. Hanley & Belfus, Philadelphia. M. Rotblatt, I. Ziment (Eds.).
49. Meoli A.M., Rosen C., Kristo D., et al. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med 2005, 1(2):173-187.
50. Hadley S., Petry J. Valerian. Am Fam Physician 2003, 67(8):1755-1758.
51. Donath F., Quispe S., Diefenbach K., et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000, 33:47-53.
52. Muller S., Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 2006, 13:383-387.
53. Francis A., Dempster R. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomized trial. Phytomedicine 2002, 9:273-279.
54. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 2005, 19(4):414-421.
55. Kuhlmann J., Berger W., Podzuweit H., et al. The influence of valerian treatment on "reaction time, alertness, and concentration" in volunteers. Pharmacopsychiatry 1999, 32:235-241.
56. MacGregor F., Abernathy V., Dahabra S., et al. Hepatotoxicity of herbal remedies. Br Med J 1989, 299:1156-1157.
57. Pepping J. Kava: Piper methysticum. Am J Health Syst Pharm 1999, 56:957-960.
58. Singh Y., Singh N. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 2002, 16(11):731-743.
59. Pittler M., Ernst E. Kava extract versus placebo for treating anxiety. Cochrane Database Syst Rev 2010, 6. [review], CD003383.
60. Stevinson C., Huntley A., Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Saf 2002, 25(4):251-261.
61. Hepatic toxicity possibly associated with kava-containing products-United States, Germany and Switzerland, 1999-2002. JAMA 2003, 289(1):36-37.
62. Kava (Piper methysticum). Evidence-based herbal medicine 2002, 244-247. Hanley & Belfus, Philadelphia. M. Rotblatt, I. Ziment (Eds.).
63. Schelosky L., Raffauf C., Jendroska K., et al. Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry 1995, 58:639-640.
64. Sayeed S., Bloch R., Antonacci D. Herbal and dietary supplements for treatment of anxiety disorders. Am Fam Physician 2007, 76:549-556.
65. Clayton E., Hanstock T., Garg M., et al. Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta Neuropsychiatr 2007, 19:92-103.
66. Burlotte J., Bukutu C., Vohra S. Complementary, holistic, and integrative medicine: fish oils and neurodevelopmental disorders. Pediatr Rev 2009, 30(4):e29-e33.
67. Raz R., Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol 2009, 51:580-592.
68. Richardson A. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry 2006, 18(2):155-172.
69. Nemets H., Nemets B., Apter A., et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006, 163:1098-1100.
70. Clayton E., Hanstock T., Hirneth S., et al. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr 2009, 63:1037-1040.
71. Wozniak J., Biederman J., Mick E., et al. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol 2007, 17:440-447.
72. Natural Medicines Comprehensive Database EPA (Eicosapentaenoic acid) Available at:, Accessed August 30, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA~CP%26s=ND%26pt=9%26Product=epa%26btnSearch.x=0%26btnSearch.y=0.
73. Natural Medicines Comprehensive Database DHA (Docosahexaenoic acid) Available at:, Accessed August 30, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA~CP%26s=ND%26pt=9%26Product=dha%26btnSearch.x=0%26btnSearch.y=0.
74. Seamon M., Clauson K. Ephedra: yesterday, DSHEA, and tomorrow-a ten year perspective on the dietary supplement health and education act of 1994. J Herb Pharmacother 2005, 5:67-86.
75. Natural Medicines Comprehensive Database Guarana Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA~CP%26s=ND%26pt=9%26Product=guaran%26btnSearch.x=0%26btnSearch.y=0.
76. Natural Medicines Comprehensive Database Citrus aurantium Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx%3Fcs%3DMHSLA%7ECP%26s%3DND%26pt%3D9%26Product%3Dcitrus%2Baurantium%26btnSearch.x%3D13%26btnSearch.y%3D5.
77. Natural Medicines Comprehensive Database Chromium picolinate Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA%7ECP%26s=ND%26pt=9%26Product=chromium%2Bpicolinate%26btnSearch.x=12%26btnSearch.y=9.
78. Natural Medicines Comprehensive Database Garcinia cambogia Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA%7ECP%26s=ND%26pt=9%26Product=garcinia%2Bcambogia%26btnSearch.x=15%26btnSearch.y=8.
79. Natural Medicines Comprehensive Database Chitosan Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA%7ECP%26s=ND%26pt=9%26Product=chitosan%26btnSearch.x=9%26btnSearch.y=7.
80. Natural Medicines Comprehensive Database Pyruvate Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA%7ECP%26s=ND&pt=9%26Product=Pyruvate%26btnSearch.x=8%26btnSearch.y=14.
81. Natural Medicines Comprehensive Database Gingko biloba Available at:, Accessed September 14, 2010. http://0-naturaldatabase.therapeuticresearch.com.libcat.ferris.edu/nd/Search.aspx?cs=MHSLA%7ECP%26s=ND%26pt=9%26Product=ginkgo%2Bbiloba%26btnSearch.x=13%26btnSearch.y=11.